Factor IX activity (1:40)

This test measures the functional activity of factor IX, a vitamin K dependent protein that helps your blood form stable clots. It is performed on platelet-poor plasma using a standardized, fixed-dilution clotting assay, and reports how well factor IX is working rather than simply how much is present.

Factor IX activity testing is part of a detailed evaluation of the intrinsic pathway of coagulation. It is commonly used alongside other clotting tests to build a clear picture of your clotting system and to support diagnosis and management decisions.

Results help identify hemophilia B, an inherited condition in which factor IX does not function properly, as well as acquired deficiencies related to vitamin K lack, liver disease, certain medications, or inhibitors that block factor IX. Knowing your factor IX activity guides treatment planning, including replacement therapy and preparation for procedures where bleeding control is important.

Clinicians also order this test to investigate unexplained bruising, joint or muscle bleeds, or an abnormal screening test such as an aPTT. In some circumstances, higher than expected activity has been linked to increased clot risk, so your result is interpreted alongside your history, exam, and other laboratory findings.

If your activity is lower than the laboratory reference interval, your clinician may confirm the finding with a repeat sample and perform additional tests such as a mixing study or an inhibitor screen. They may also review medications, nutrition, and liver health. For people with known hemophilia B, activity measurements help tailor dosing of factor IX concentrates and assess treatment response.

If your activity is higher than expected, your care team will consider factors like inflammation, pregnancy, or other clotting risk factors. Do not change or stop any medication without medical advice. Follow-up plans are individualized, and your clinician will explain whether more testing or preventive steps are needed.